Evra® [Norelgestromin, Ethinyl estradiol]

Indications for use:

Contraception in women 18-45 years old.

Properties:

The adhesive patch contains a minimum amount of hormones, which, due to uniform absorption, show high efficiency;

Stimulates changes in the composition of the mucus covering the cervix, making it difficult for sperm to move into the uterus.

Composition and form of release:

Evra transdermal patch (through the skin) No. 3

Norelgestromine 6 mg;

Ethinyl estradiol 0.75 mg.

Benefits:

This contraceptive method has a big plus: it cannot be "forgotten" to apply;

Adhesive plaster is convenient to use, it is easily attached to your skin and does not exfoliate under the influence of the sun or water;

Like other hormonal contraceptives, the adhesive plaster exhibits healing properties: when it is used, bloody intermenstrual discharge disappears, menstrual pains appear much less often.

Mode of application:

Euro is attached once a week for 3 weeks (21 days), with a weekly break;

Contraception with the contraceptive patch Evra begins on the first day of menstruation. Evra patch is attached and removed on the same day of the week;

During the 4th week, from the 22nd to the 28th day of the cycle, Evra is not used. A new contraceptive cycle begins the day after the end of the 4th week;

The next Evra patch should be glued, even if there was no menstruation or it did not end.

Contraindications:

Hemorrhoids;

Heart failure;

Ulcerative lesions of the stomach;

High blood pressure;

Diabetes;

Obesity;

Migraine;

Impaired liver function;

Pregnancy;

Oncological and gynecological diseases;

Suspicion of pregnancy

Bleeding.

Side effects:

Dizziness, migraine;

Phlebeurysm;

Increased blood pressure;

Abdominal pain, vomiting;

Upper respiratory tract infections;

Urinary tract infections;

Allergic reactions.

Special instructions:

Before starting or resuming the use of the contraceptive patch Evra, it is necessary to exclude pregnancy.